- A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals
May 17, 2026
Key Points
Initiated new stake: 2,296,335 shares; estimated trade value $43.78 million (based on quarterly average price) Quarter-end position value at $41.54 million, representing a net valuation change that includes price movements Trade represented a 1.89% increase in 13F reportable assets under management Post-trade: 2,296,335 shares held, valued at $41.54 million Position accounts for 1.79% of 13F AUM, which places it outside the fund's top five holdings10 stocks we like better than Legend Biotech ›
First Beijing Investment Ltd disclosed a new position in Legend Biotech(NASDAQ:LEGN), acquiring 2,296,335 shares in the first quarter, with the estimated trade valued at $43.78 million based on average quarterly pricing, according to a May 13, 2026, SEC filing.
Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.
Initiated new stake: 2,296,335 shares; estimated trade value $43.78 million (based on quarterly average price)Quarter-end position value at $41.54 million, representing a net valuation change that includes price movementsTrade represented a 1.89% increase in 13F reportable assets under managementPost-trade: 2,296,335 shares held, valued at $41.54 millionPosition accounts for 1.79% of 13F AUM, which places it outside the fund's top five holdings
What happened
According to an SEC filing dated May 13, 2026, First Beijing Investment Ltd established a new stake in Legend Biotech, purchasing 2,296,335 shares. The estimated transaction value was $43.78 million, calculated using the average closing price for the first quarter. The quarter-end value of this position stood at $41.54 million, reflecting both purchase activity and share price movement during the period.
What else to know
New position: stake represents 1.79% of 13F reportable assets under management as of March 31, 2026Top holdings after the filing:
NASDAQ: PDD: $832.68 million (35.9% of AUM)NYSE: YMM: $747.01 million (32.2% of AUM)NYSE: EDU: $509.40 million (22.0% of AUM)NYSE: RLX: $132.29 million (5.7% of AUM)NASDAQ: KSPI: $32.17 million (1.4% of AUM)As of May 15, 2026, Legend Biotech shares were priced at $27.55, down 0.5% over the prior year, underperforming the S&P 500 by 25.7 percentage points
Company Overview MetricValuePrice (as of market close 2026-05-15)$27.55Market Capitalization$5.08 billionRevenue (TTM)$1.14 billionNet Income (TTM)($250.98 million)
Company Snapshot
Legend Biotech develops and commercializes novel cell therapies, including its lead CAR-T product candidate for multiple myeloma and a pipeline targeting various hematologic malignancies and solid tumors.The company generates revenue primarily through the development and licensing of its cell therapy portfolio, leveraging strategic collaborations such as its agreement with Janssen Biotech for ciltacabtagene autoleucel.Legend Biotech targets oncology patients, healthcare providers, and pharmaceutical partners in the United States, China, and international markets.
Legend Biotech Corporation is a clinical-stage biopharmaceutical company focused on advancing innovative cell therapies for cancer and related diseases. The company leverages proprietary CAR-T technologies and strategic partnerships to address high unmet medical needs in oncology. With a growing portfolio and international presence, Legend Biotech aims to establish a competitive position in the global biotechnology sector.
What this transaction means for investors
First Beijing runs a hyper-concentrated book — three names make up roughly 90% of its reported assets, all in Chinese tech and consumer. Adding Legend Biotech at 1.79% of AUM is a toe-dip into a different corner of the China ADR universe, not a conviction call. The stock had already given back meaningful ground before this position was opened, which is worth knowing, but the filing doesn't tell you why First Beijing bought or what their target is. A small new position from a fund this concentrated says less than the same allocation would from a more diversified manager. If you're trying to decide whether Legend Biotech belongs in your portfolio, the CAR-T pipeline and the Janssen partnership are the questions that matter — this 13F just tells you one institution got off the sidelines at a depressed price.
Should you buy stock in Legend Biotech right now?
Before you buy stock in Legend Biotech, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Legend Biotech wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!*
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 17, 2026.
Seena Hassouna has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Joint Stock Kaspi.kz and Legend Biotech. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
- A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals
May 17, 2026
First Beijing Investment Ltd disclosed a new position in Legend Biotech(NASDAQ:LEGN), acquiring 2,296,335 shares in the first quarter, with the estimated trade valued at $43.78 million based on average quarterly pricing, according to a May 13, 2026, SEC filing.
Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.
Initiated new stake: 2,296,335 shares; estimated trade value $43.78 million (based on quarterly average price) Quarter-end position value at $41.54 million, representing a net valuation change that includes price movements Trade represented a 1.89% increase in 13F reportable assets under management Post-trade: 2,296,335 shares held, valued at $41.54 million Position accounts for 1.79% of 13F AUM, which places it outside the fund's top five holdings
What happened
According to an SEC filing dated May 13, 2026, First Beijing Investment Ltd established a new stake in Legend Biotech, purchasing 2,296,335 shares. The estimated transaction value was $43.78 million, calculated using the average closing price for the first quarter. The quarter-end value of this position stood at $41.54 million, reflecting both purchase activity and share price movement during the period.
What else to know
New position: stake represents 1.79% of 13F reportable assets under management as of March 31, 2026 Top holdings after the filing:
NASDAQ: PDD: $832.68 million (35.9% of AUM) NYSE: YMM: $747.01 million (32.2% of AUM) NYSE: EDU: $509.40 million (22.0% of AUM) NYSE: RLX: $132.29 million (5.7% of AUM) NASDAQ: KSPI: $32.17 million (1.4% of AUM) As of May 15, 2026, Legend Biotech shares were priced at $27.55, down 0.5% over the prior year, underperforming the S&P 500 by 25.7 percentage points
Company Overview
Metric Value Price (as of market close 2026-05-15) $27.55 Market Capitalization $5.08 billion Revenue (TTM) $1.14 billion Net Income (TTM) ($250.98 million)
Company Snapshot
Legend Biotech develops and commercializes novel cell therapies, including its lead CAR-T product candidate for multiple myeloma and a pipeline targeting various hematologic malignancies and solid tumors. The company generates revenue primarily through the development and licensing of its cell therapy portfolio, leveraging strategic collaborations such as its agreement with Janssen Biotech for ciltacabtagene autoleucel. Legend Biotech targets oncology patients, healthcare providers, and pharmaceutical partners in the United States, China, and international markets.
Legend Biotech Corporation is a clinical-stage biopharmaceutical company focused on advancing innovative cell therapies for cancer and related diseases. The company leverages proprietary CAR-T technologies and strategic partnerships to address high unmet medical needs in oncology. With a growing portfolio and international presence, Legend Biotech aims to establish a competitive position in the global biotechnology sector.
Story Continues
What this transaction means for investors
First Beijing runs a hyper-concentrated book — three names make up roughly 90% of its reported assets, all in Chinese tech and consumer. Adding Legend Biotech at 1.79% of AUM is a toe-dip into a different corner of the China ADR universe, not a conviction call. The stock had already given back meaningful ground before this position was opened, which is worth knowing, but the filing doesn't tell you why First Beijing bought or what their target is. A small new position from a fund this concentrated says less than the same allocation would from a more diversified manager. If you're trying to decide whether Legend Biotech belongs in your portfolio, the CAR-T pipeline and the Janssen partnership are the questions that matter — this 13F just tells you one institution got off the sidelines at a depressed price.
Should you buy stock in Legend Biotech right now?
Before you buy stock in Legend Biotech, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Legend Biotech wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!*
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 17, 2026.
Seena Hassouna has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Joint Stock Kaspi.kz and Legend Biotech. The Motley Fool has a disclosure policy.
A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals was originally published by The Motley Fool
View Comments
- With YMM Down 29%, First Beijing Bought 13 Million More Shares
May 17, 2026
First Beijing Investment Ltd disclosed in a May 13, 2026, SEC filing that it bought 13,384,327 shares of Full Truck Alliance(NYSE:YMM), an estimated $127.30 million trade based on quarterly average pricing.
What happened
According to a SEC filing dated May 13, 2026, First Beijing Investment Ltd increased its stake in Full Truck Alliance by 13,384,327 shares. The estimated trade value is $127.30 million, calculated using the average closing price for the first quarter of 2026. As a result, the quarter-end position’s value fell by $75.09 million, a change driven by both additional shares and stock price fluctuations.
What else to know
The fund’s buy lifted its Full Truck Alliance stake to 32.22% of its 13F assets under management as of March 31, 2026 Top holdings after the filing:
NASDAQ: PDD: $832.68 million (35.9% of AUM) NYSE: EDU: $509.40 million (22.0% of AUM) NYSE: RLX: $132.29 million (5.7% of AUM) NASDAQ: LEGN: $41.54 million (1.8% of AUM) NASDAQ: KSPI: $32.17 million (1.4% of AUM) As of May 15, 2026, Full Truck Alliance shares were priced at $8.66, down 30.6% over one year and lagging the S&P 500 by 55.82 percentage points
Company Overview
Metric Value Price (as of market close May 15, 2026) $8.66 Market capitalization $8.98 billion Revenue (TTM) $1.73 billion Net income (TTM) $619.53 million
Company Snapshot
Offers a digital freight platform connecting shippers with truckers, providing freight listing, matching, brokerage, online transaction services, and value-added solutions such as credit, insurance, toll, and energy services. Generates revenue primarily through transaction fees, value-added services, and technology development, leveraging a network-driven, platform-based business model. Targets shippers and truckers across China, serving logistics needs for businesses of varying sizes and cargo types.
Full Truck Alliance operates at scale as a leading digital freight platform in China, facilitating efficient connections between shippers and truckers. The company’s strategy centers on technology-driven logistics solutions and a broad suite of value-added services, enhancing its competitive position in the rapidly evolving transportation sector.
What this transaction means for investors
First Beijing Investment is not a diversified fund. After this buy, its top two positions — PDD Holdings and Full Truck Alliance — account for roughly 68% of its reported 13F assets. Adding 13.4 million YMM shares into a stock that's down 29% over the prior year isn't a contrarian signal so much as an expression of existing conviction: the fund has been in this trade and is staying in it. The position value still fell $75 million quarter-over-quarter despite the higher share count. That's the math of buying into a declining stock — more shares, lower price, net value down. There's no hidden accounting effect here. For investors watching this filing for a signal, the relevant question isn't whether First Beijing likes YMM — clearly it does. It's whether you share the thesis on a Chinese digital freight platform at a time when the stock is pricing in real doubt. First Beijing's concentrated style means this filing reflects a deliberate, undiversified bet on a small set of Chinese ADRs. That's context worth having before you follow institutional money into a position this size.
Story Continues
Should you buy stock in Full Truck Alliance right now?
Before you buy stock in Full Truck Alliance, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Full Truck Alliance wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!*
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 17, 2026.
Seena Hassouna has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Joint Stock Kaspi.kz and Legend Biotech. The Motley Fool has a disclosure policy.
With YMM Down 29%, First Beijing Bought 13 Million More Shares was originally published by The Motley Fool
View Comments
- With YMM Down 29%, First Beijing Bought 13 Million More Shares
May 17, 2026 · fool.com
Full Truck Alliance is a top digital freight platform in China, connecting shippers and truckers through tech-enabled logistics services.
- DLocal (DLO) Q1 Earnings and Revenues Beat Estimates
May 14, 2026
DLocal (DLO) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +6.25%. A quarter ago, it was expected that this online payment company would post earnings of $0.18 per share when it actually produced earnings of $0.22, delivering a surprise of +22.22%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
DLocal, which belongs to the Zacks Financial Transaction Services industry, posted revenues of $335.86 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.93%. This compares to year-ago revenues of $216.76 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
DLocal shares have lost about 13.9% since the beginning of the year versus the S&P 500's gain of 8.8%.
What's Next for DLocal?
While DLocal has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for DLocal was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.20 on $355.42 million in revenues for the coming quarter and $0.85 on $1.5 billion in revenues for the current fiscal year.
Story Continues
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial Transaction Services is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the broader Zacks Business Services sector, Full Truck Alliance Co. Ltd. Sponsored ADR (YMM), has yet to report results for the quarter ended March 2026. The results are expected to be released on May 21.
This company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of -27.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Full Truck Alliance Co. Ltd. Sponsored ADR's revenues are expected to be $403.53 million, up 8.5% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DLocal Limited (DLO) : Free Stock Analysis Report
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- Full Truck Alliance (YMM) Soars 5.5%: Is Further Upside Left in the Stock?
May 14, 2026
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) shares ended the last trading session 5.5% higher at $9.27. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.8% gain over the past four weeks.
The stock is benefiting from improving sentiment around Full Truck Alliance’s long-term digital freight platform growth prospects and broader strength across Chinese ADRs.
This company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of -27.8%. Revenues are expected to be $403.53 million, up 8.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Full Truck Alliance, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on YMM going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Full Truck Alliance is part of the Zacks Technology Services industry. Skillsoft Corp. (SKIL), another stock in the same industry, closed the last trading session 3.3% lower at $7.44. SKIL has returned 40.6% in the past month.
For Skillsoft, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.05. This represents a change of -83.3% from what the company reported a year ago. Skillsoft currently has a Zacks Rank of #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) : Free Stock Analysis Report
Skillsoft Corp. (SKIL) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- Full Truck Alliance (YMM) Soars 5.5%: Is Further Upside Left in the Stock?
May 14, 2026 · zacks.com
Full Truck Alliance (YMM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- QXO, Inc. (QXO) Reports Q1 Loss, Beats Revenue Estimates
May 12, 2026
QXO, Inc. (QXO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -29.73%. A quarter ago, it was expected that this company would post earnings of $0.03 per share when it actually produced earnings of $0.02, delivering a surprise of -33.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
QXO INC, which belongs to the Zacks Technology Services industry, posted revenues of $1.73 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.67%. This compares to year-ago revenues of $13.51 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
QXO INC shares have lost about 4.4% since the beginning of the year versus the S&P 500's gain of 8.3%.
What's Next for QXO INC?
While QXO INC has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for QXO INC was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.13 on $3.25 billion in revenues for the coming quarter and $0.36 on $11.4 billion in revenues for the current fiscal year.
Story Continues
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Technology Services is currently in the bottom 21% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Full Truck Alliance Co. Ltd. Sponsored ADR (YMM), has yet to report results for the quarter ended March 2026. The results are expected to be released on May 21.
This company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of -27.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Full Truck Alliance Co. Ltd. Sponsored ADR's revenues are expected to be $403.53 million, up 8.5% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
QXO, Inc. (QXO) : Free Stock Analysis Report
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- China-Focused Serenity Capital Boosts "Uber for Trucks" Stake by $17.9 Million
May 12, 2026
On May 12, 2026, Serenity Capital Management disclosed a buy of Full Truck Alliance(NYSE:YMM), adding 1,880,010 shares in a transaction estimated at $17.88 million based on quarterly average pricing.
What happened
According to a Securities and Exchange Commission (SEC) filing dated May 12, 2026, Serenity Capital Management increased its stake in Full Truck Alliance by 1,880,010 shares. The estimated transaction value, based on the average closing price for the first quarter of 2026, was $17.88 million. The quarter-end position value rose by $11.21 million, a figure that includes both trading activity and changes in share price.
What else to know
The buy brings the Full Truck Alliance stake to 7.39% of the fund’s reportable U.S. equity assets. Top holdings after the filing:
NYSE:ZTO: $127.28 million (30.7% of AUM) NYSE:TAL: $53.78 million (13.0% of AUM) NASDAQ:HTHT: $48.23 million (11.6% of AUM) NYSE:EDU: $37.20 million (9.0% of AUM) NASDAQ:PDD: $36.78 million (8.9% of AUM) As of May 11, 2026, shares were priced at $8.79, down 29.1% over the past year, underperforming the S&P 500 by 53.39 percentage points.
Company Overview
Metric Value Market Capitalization $9.08 billion Revenue (TTM) $1.83 billion Net Income (TTM) $647.06 million Dividend Yield 2.07%
Company Snapshot
Offers a digital freight platform connecting shippers and truckers, with services including freight listing, matching, brokerage, online transactions, credit solutions, insurance, electronic toll collection, and energy services. Generates revenue through transaction fees, value-added services, and technology solutions that streamline logistics and supply chain operations. Serves shippers and trucking companies across China, targeting businesses seeking efficient, technology-driven freight solutions.
Full Truck Alliance operates a digital freight platform in China, facilitating connections between shippers and truckers. The company provides integrated technology and value-added services for its customer base.
What this transaction means for investors
Serenity Capital Management runs a highly concentrated China-focused portfolio — nine of their 10 holdings are Chinese companies. During Q1, they added nearly $18 million to Full Truck Alliance, bringing it to roughly 7% of their portfolio.
Full Truck Alliance operates a mobile marketplace connecting shippers with truckers across China, kind of like Uber for freight. The company announced a shareholder-friendly capital return plan in January, committing to distribute at least half of annual earnings through dividends and buybacks, starting with $400 million in 2026.
Story Continues
The business is growing. Transaction commission revenue is expected to surge 30% this year as the company scales its core freight-matching business. Order volumes are climbing steadily and the platform continues adding users.
For investors considering Chinese tech stocks, Full Truck Alliance represents a bet on digitizing China's fragmented trucking industry. The shareholder return plan adds income to a growth story. The risk is regulatory uncertainty and competition in a market where logistics platforms are multiplying fast.
Should you buy stock in Full Truck Alliance right now?
Before you buy stock in Full Truck Alliance, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Full Truck Alliance wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $460,826!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,345,285!*
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 12, 2026.
Sara Appino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Uber Technologies. The Motley Fool has a disclosure policy.
China-Focused Serenity Capital Boosts "Uber for Trucks" Stake by $17.9 Million was originally published by The Motley Fool
View Comments
- China-Focused Serenity Capital Boosts "Uber for Trucks" Stake by $17.9 Million
May 12, 2026 · fool.com
This China-based logistics technology firm connects shippers and truckers through a digital freight platform and value-added services.
